The Diagnostic and Disease Control Center constructed under the agreement reached between the Kano State government and pharmaceutical company Pfizer in respect of the 1996 Trovan clinical trials has been completed and is ready to take-off.
Disclosing this during a facility tour of the center, the Executive Secretary of Pfizer, Mr. David Odiwo, said in view of the agreement, Pfizer would underwrite $30 million several healthcare initiatives chosen by the state government which would be of benefit to people of the state, adding that with respect to that agreement, an independent board of trustees and the Healthcare Related Programs Trust Board were established to administer and oversee the funds.
He said following the choice of the state government and its subsequent provision of land to that effect, the board commenced work on the construction of the DDCC in Dawakin Kudu Local Government in 2010.
“The over $25.5 million facility sits on 2.9 hectares and it is completely and fully equipped with the state-of-the-art modern healthcare facilities and it is ready to be handed over to Kano State,” he said. According to him, the 100-bed patients ward health facility center has been constructed in such a way that it would provide facilities for the training of medical doctors and other key healthcare professionals in the country and cater for researches into infectious diseases such as malaria and cholera among others.